MHRA resumes international Inspections
Recommendation
26/27 June 2025
Barcelona, Spain
Supervision of the Pharmaceutical Supply Chain: Challenges and Opportunities
Register now for ECA's GMP Newsletter
Right at the start of the Covid 19 pandemic, in March 2020, the UK MHRA published a blog post on the progress of on-site inspections. These were limited to inspections related to the UK government's COVID-19 response or other potential serious public health risks. As the pandemic and developments unfolded, more on-site inspections were then carried out again in the UK. However, there was not really a return to international inspections.
Meanwhile, international travel has become easier to organise again. A pilot programme has started in April 2022 to look at a possible return to international GMP on-site inspections. In a MHRA Inspecctorate Blog entitled "Return to International GMP Inspections" now published, it is announced that the pilot project was successful and the MHRA is resuming the programme of international GMP on-site inspections, albeit with restrictions. A risk-based approach will be taken.
Validity of GMP certificates
During the pandemic, a "pragmatic approach" was taken to the validity of GMP certificates. These were first extended to the end of 2021 and then to the end of 2022. The blog now also states that GMP certificates issued by the MHRA will be extended again until the end of 2023.
Related GMP News
21.05.2025More FDA Warning Letters citing Quality Oversight
21.05.2025New Version of GMP Auditors Handbook available
21.05.2025FDA: more unannounced Inspections also outside the US
14.05.2025How does FDA train and guide its Inspectors?
30.04.2025QP Declaration: New Q&As published
19.03.2025Root Cause Analysis: Again, problems discovered in GMP-Inspections